Stephens & Co. Downgrades Humana to Equal-Weight, Lowers Price Target to $250
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. has downgraded Humana from Overweight to Equal-Weight and reduced its price target from $400 to $250.
October 02, 2024 | 5:05 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Stephens & Co. has downgraded Humana from Overweight to Equal-Weight and significantly lowered its price target from $400 to $250.
The downgrade from Overweight to Equal-Weight and the significant reduction in the price target from $400 to $250 by Stephens & Co. suggests a negative outlook on Humana's stock performance. This is likely to lead to a short-term decline in Humana's stock price as investors react to the analyst's revised expectations.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100